Davita Inc vs Vanguard Real Estate Index Fund ETF — how do they compare? Davita Inc trades at $179.58 (market cap $11.38B), while Vanguard Real Estate Index Fund ETF trades at $97.16. The key difference: Vanguard Real Estate Index Fund ETF is trading nearer its 52-week high, Davita Inc nearer its low. Which is the better fit depends on your goals.
| DVA | VNQ | |
|---|---|---|
Market Cap | $11.38B | — |
Sector | Health | — |
52-Week High | $240.96 | $100.95 |
52-Week Low | $103.87 | $87.00 |
Enterprise Value | $24.10B | — |
Signals from Pluang's Aura AI — not financial advice
DaVita (DVA) trades at $183.69, down slightly by 0.04% over the past day. The stock shows strong fundamental performance with consistent earnings beats in recent quarters, including Q2 2026 EPS of $4.02 versus $3.88 expected (Zacks Investment Research, 2026-08-04). However, technical indicators signal a bearish trend, with the price near key support at $182. Revenue growth remains steady, climbing to $13.64 billion in 2025, though net income margin dipped to 5.47%.
The outlook is mixed; analyst consensus leans bullish with a $232.25 price target (MarketBeat, 2026-08-05), but risks include reimbursement pressure and high debt levels. Investment appeal hinges on execution against guidance amid payer-mix challenges, with the current valuation offering potential upside if operational trends stabilize.
VNQ (Vanguard Real Estate ETF) trades at $96.745, down 0.38% on the day amid a bearish technical signal. The ETF shows mixed momentum with oversold short-term RSI readings but bearish moving averages. Recent institutional selling activity from firms like Bank of America and City Holding Co. indicates cautious positioning in the real estate sector. The fund's dividend yield remains a key attraction for income-focused investors.
The outlook for VNQ is challenged by rising interest rate sensitivity and institutional outflows, though the oversold RSI suggests potential for near-term stabilization. Investors should weigh the ETF's low expense ratio and U.S. REIT diversification against sector-specific headwinds including commercial real estate pressures and economic uncertainty.
Trailing returns across standard periods
Latest headlines on both assets
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Real Estate 25/50 Index, an index made up of stocks of large, mid-size, and small US companies within the real estate sector. The Advisor attempts to replicate the target index by seeking to invest all of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. It is non-diversified.
Read more on VNQ →